March 27, 2024
CMIC HOLDINGS Co., Ltd.
At the extraordinary general meeting of shareholders held on March 4, 2024, the Company’s shareholders approved the proposal for the consolidation of shares as proposed. As a result, the Company’s common shares will fall under the delisting criteria set forth in the rules for listing of securities of the Tokyo Stock Exchange, Inc., and will be delisted as of March 28, 2024.
For details, please refer to our press release dated March 4, 2024, entitled “Notice Concerning Resolution to Approve Share Consolidation, Abolition of the Number of Shares Constituting One Unit of Shares, and Partial Amendments to the Articles of Incorporation”.
We would like to take this opportunity to express our sincere appreciation to our shareholders and other stakeholders for their deep support and understanding of our management over the years.
We are committed to further enhancing our corporate value and contributing to the society. We look forward to your continued understanding and support.
The post Notice Concerning Delisting of Company Shares appeared first on CMIC | Pharmaceutical Development Services (CRO, CDMO, CSO, Healthcare, Japan Entry).